3-Quinolinecarboxamide, 1,2-dihydro-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)-2-oxo- manufacturers
- PBS-1086
-
- $2500.00
-
2026-04-21
- CAS:1246668-32-5
- Purity:
- Supply Ability: 10g
|
| | 3-Quinolinecarboxamide, 1,2-dihydro-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)-2-oxo- Basic information |
| | 3-Quinolinecarboxamide, 1,2-dihydro-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)-2-oxo- Chemical Properties |
| Boiling point | 755.7±60.0 °C(Predicted) | | density | 1.59±0.1 g/cm3(Predicted) | | pka | 10.13±0.40(Predicted) |
| | 3-Quinolinecarboxamide, 1,2-dihydro-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)-2-oxo- Usage And Synthesis |
| Description | PBS-1086 is a novel dual inhibitor of the canonical and noncanonical NF-κB pathways, increasing the magnitude and duration of initial EGFR inhibitor response in multiple NSCLC models, decreasing PDHK1 expression, and suppressing phosphorylation of the PDHK1 protein substrate PDHA1 in a panel of PTEN-deficient cell lines. |
| | 3-Quinolinecarboxamide, 1,2-dihydro-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)-2-oxo- Preparation Products And Raw materials |
|